Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Minnesota
About this trial
This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.
Eligibility criteria
Qualifiers
Pregnant individuals aged 18 years or older
Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks of gestation, confirmed by last menstrual period or ultrasound
Diagnosed with mild to moderate NVP (PUQE-24 score between 4-12)
Ability to understand and read English
Disqualifiers
Severe nausea and vomiting, defined as a PUQE score >12, or diagnosis of hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy
Pre-existing, active or acute respiratory conditions (e.g., asthma, COPD)
History of severe anxiety disorders affecting breathing patterns
Known deviated nasal septum
Trial design
Treatments tested in this trial
- Alternate Nostril Breathing
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov